Y
Yujing Jiang
Researcher at Southern University of Science and Technology
Publications - 3
Citations - 2042
Yujing Jiang is an academic researcher from Southern University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 1704 citations.
Papers
More filters
Journal ArticleDOI
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Chenguang Shen,Zhaoqin Wang,Fang Zhao,Yang Yang,Jinxiu Li,Jing Yuan,Fuxiang Wang,Delin Li,Delin Li,Minghui Yang,Li Xing,Jinli Wei,Haixia Xiao,Haixia Xiao,Yan Yang,Jiuxin Qu,Ling Qing,Li Chen,Zhixiang Xu,Ling Peng,Yanjie Li,Haixia Zheng,Feng Chen,Kun Huang,Yujing Jiang,Dongjing Liu,Zheng Zhang,Yingxia Liu,Lei Liu +28 more
TL;DR: In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status, and these observations require evaluation in clinical trials.
Journal ArticleDOI
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
Yang Yang,Xiao-qian Gong,Liuqing Yang,Jie Liu,Jiaqi Zhang,Lanlan Wei,Guoguo Ye,Yimin Tang,Yujing Jiang,Jian-Hua Li,Yuan-Long Lin,Fu-Sheng Wang,Hongzhou Lu,Yingxia Liu +13 more
TL;DR: Gidari et al. as discussed by the authors evaluated the neutralizing activity of COVID-19 convalescents with wild type SARS-CoV-2 and different VOCs, and vaccinees with both regular vaccination and homologous booster of inactivated vaccine.
Journal ArticleDOI
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis
Wencong Zhang,Ming-You Xing,Wenjin Sun,Jia Chen,Na-na Xie,Yuanfa Cai,Ying Wang,Niuniu Li,Yujing Jiang,Fan Zhang,Qingjin Zeng,Yanhua Ji,Cheng Xu,Chun-feng Jiang,Jianxin Song,Guojun Li +15 more
TL;DR: In this article , the clinical efficacy of peg-IFNα in two populations with HBV infection, including inactive HBsAg carrier (IHC) and chronic hepatitis B (CHB), was investigated.